Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × Radiotherapy × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 47 Glioblastoma 46 Prostatic Neoplasms 43 Carcinoma, Non-Small-Cell Lung 41 Squamous Cell Carcinoma of Head and Neck 32 Head and Neck Neoplasms 24 Lung Neoplasms 22 Neoplasms 20 Rectal Neoplasms 19 Glioma 19 Brain Neoplasms 18 Sarcoma 16 Uterine Cervical Neoplasms 14 Esophageal Neoplasms 13 Pancreatic Neoplasms 12 Neoplasm Metastasis 12 Oropharyngeal Neoplasms 11 Esophageal Squamous Cell Carcinoma 11 Astrocytoma 11 Melanoma 10 Gliosarcoma 10 Triple Negative Breast Neoplasms 9 Colorectal Neoplasms 9 Stomach Neoplasms 8 Lymphoma 8 Hodgkin Disease 8 Carcinoma, Squamous Cell 8 Carcinoma, Renal Cell 8 Carcinoma, Hepatocellular 8 Urinary Bladder Neoplasms 7

Interventions

Nivolumab 6 Ipilimumab 5 Cisplatin 5 atezolizumab 4 Carboplatin 4 Etoposide 3 gallium Ga 68 dotatate 2 dostarlimab 2 Temozolomide 2 Positron Emission Tomography Computed Tomography 2 Paclitaxel 2 Magnetic Resonance Imaging 2 Immunoglobulin G 2 Drug Therapy 2 Disulfides 2 zimberelimab 1 tivozanib 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 niraparib 1 lutetium Lu 177 dotatate 1 iadademstat 1 durvalumab 1 cabozantinib 1 budigalimab 1 berzosertib 1 belinostat 1 Topotecan 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡